ADAM17 and neoplasm: On the one hand, although the regulatory effect of ADAM17 on macrophages, NK cells, and endothelial cells has been confirmed in tumor, more key proteins or genes related to ADAM17 need to be identified, and the immune response involved in TME needs to be further explored.